Developing dietary supplements for the treatment of muscle cramps and spasms.
Industry: Health Care
First Day Return: -6.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/29/2014 |
Offer Price | $16.00 |
Price Range $12.00 - $14.00 | |
Offer Shares (mm) | 5.4 |
Deal Size ($mm) | $86 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 01/28/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $86 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Boston, MA, United States |
Founded | 2014 |
Employees at IPO | 14 |
Website www.salariuspharma.com |